Keros Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KROS and other ETFs, options, and stocks.

About KROS

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. 

CEO
Jasbir S. Seehra
CEOJasbir S. Seehra
Employees
169
Employees169
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2015
Founded2015
Employees
169
Employees169

KROS Key Statistics

Market cap
424.39M
Market cap424.39M
Price-Earnings ratio
9.20
Price-Earnings ratio9.20
Dividend yield
Dividend yield
Average volume
343.82K
Average volume343.82K
High today
$14.37
High today$14.37
Low today
$13.84
Low today$13.84
Open price
$14.00
Open price$14.00
Volume
374.45K
Volume374.45K
52 Week high
$22.55
52 Week high$22.55
52 Week low
$9.12
52 Week low$9.12

Stock Snapshot

With a market cap of 424.39M, Keros Therapeutics(KROS) trades at $13.91. The stock has a price-to-earnings ratio of 9.20.

During the trading session on 2026-03-02, Keros Therapeutics(KROS) shares reached a daily high of $14.37 and a low of $13.84. At a current price of $13.91, the stock is +0.5% higher than the low and still -3.2% under the high.

Trading volume for Keros Therapeutics(KROS) stock has reached 374.45K, versus its average volume of 343.82K.

The stock's 52-week range extends from a low of $9.12 to a high of $22.55.

The stock's 52-week range extends from a low of $9.12 to a high of $22.55.

Analyst ratings

56%

of 9 ratings
Buy
55.6%
Hold
44.4%
Sell
0%

People also own

Based on the portfolios of people who own KROS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.